Kiora Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies - Additional Information (Details)

Commitments and Contingencies - Additional Information (Details) € in Millions							1 Months Ended		3 Months Ended		9 Months Ended
	Oct. 30, 2023 USD ($)	Sep. 07, 2023 USD ($)	May 01, 2020 USD ($)	Nov. 17, 2014 EUR (€)	Sep. 12, 2013 USD ($)	Jul. 02, 2013 EUR (€)	Apr. 30, 2024 USD ($)	May 31, 2022	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($) operatingLease licenseAgreement	Sep. 30, 2023 USD ($)	Jan. 25, 2024 USD ($)	Oct. 15, 2023 ft²	Sep. 26, 2018 USD ($)
Commitments and Contingencies [Line Items]
Number of operating leases \| operatingLease											3
Total operating lease cost									$ 18,742	$ 50,482	$ 57,327	$ 121,159
Number of license agreements \| licenseAgreement											6
Payment of annual fee			$ 5,000
Payment for sublicense fee											$ 700,000
Revenues									0	$ 0	$ 16,020,000	$ 0
SentrX Animal Care Inc
Commitments and Contingencies [Line Items]
Intangible assets expected milestone payable															$ 4,750,000
For The First 250 Million Net Sales
Commitments and Contingencies [Line Items]
Percentage of royalties on net sales			2.00%
Between 250 And 500 Million Net Sales
Commitments and Contingencies [Line Items]
Percentage of royalties on net sales			1.25%
Net Sales Over 500 Million
Commitments and Contingencies [Line Items]
Percentage of royalties on net sales			0.50%
Sublease Agreement, Scenario One
Commitments and Contingencies [Line Items]
Sublicense agreement, percent of sublicense revenue											8.00%
Sublease Agreement, Scenario Two
Commitments and Contingencies [Line Items]
Sublicense agreement, percent of sublicense revenue											6.00%
Sublease Agreement, Scenario Three
Commitments and Contingencies [Line Items]
Sublicense agreement, percent of sublicense revenue											4.00%
License
Commitments and Contingencies [Line Items]
Cost of goods and services sold					$ 30,000	€ 155
License \| Licensing Agreements
Commitments and Contingencies [Line Items]
Percentage of royalties on net sales					6.00%	3.25%
KIO-101 \| Mediolanum Agreement
Commitments and Contingencies [Line Items]
Percentage of royalties on net sales				7.00%
Contractual obligation \| €				€ 20
Development and commercial milestones term				10 years
Percentage of decreasing after patent expiry				5.00%
Termination fee		$ 100,000
Termination fee payment		50,000
Termination fee payable		$ 50,000
Grant
Commitments and Contingencies [Line Items]
Revenues							$ 20,000
Théa Open Innovation \| KIO-301
Commitments and Contingencies [Line Items]
Milestone payment earned													$ 16,000,000
Maximum achievement milestone payment earned													$ 285,000,000
Percentage of royalties on net sales													20.00%
Expense offset credit									$ 900,000		$ 2,200,000
University Of California
Commitments and Contingencies [Line Items]
Licensing agreement transfer, written notice period	15 days
Licensing agreement, successor written assignment agreement, notice period	30 days
Licensing agreement, assignment fee amount	$ 30,000
Licensing agreement, execution payment amount	$ 15,000
Minimum
Commitments and Contingencies [Line Items]
Remaining lease term									6 months 29 days		6 months 29 days
Maximum
Commitments and Contingencies [Line Items]
Remaining lease term									4 years 7 months 17 days		4 years 7 months 17 days
Encinitas Lease
Commitments and Contingencies [Line Items]
Lease term								18 months
Adelaide Lease
Commitments and Contingencies [Line Items]
Lease term								12 months
Termination period								90 days
Vienna Lease
Commitments and Contingencies [Line Items]
Lease term														5 years
Area of land \| ft²														910